GLP-1 weight-loss drugs, such as Ozempic, are revolutionizing the way consumers eat, prompting food and beverage manufacturers to develop precision nutrition solutions. These solutions utilize AI and functional ingredients to personalize diets and target metabolism more effectively.
The weight-loss revolution sparked by GLP-1 drugs, including Ozempic and Mounjaro, is transforming the food industry's relationship with biology. As consumers reassess their eating habits, a parallel movement towards precision nutrition is gaining momentum.
At its core, precision nutrition involves aligning food intake with individual biological, metabolic, and behavioral characteristics.
Precision nutrition is about aligning what we eat with who we are – biologically, metabolically and behaviourally.
Author's summary: GLP-1 drugs drive precision nutrition.